$SXTC

China SXT Pharmaceuticals, Inc.

Nasdaq · Healthcare · Pharmaceutical Preparations · Taizhou

SXTC chart

What traders are saying about $SXTC

Latest posts

China SXT Pharmaceuticals, Inc. news

China SXT Pharmaceuticals, Inc. key financials

USD2025202420232022
Revenue––$1.9M$2.0M
Net income-$6.2M-$3.3M-$3.1M-$5.9M
Diluted EPS$-9.13$-348.17$-4285.66$-177.84

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

About China SXT Pharmaceuticals, Inc.

Ticker
SXTC (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
Taizhou
Incorporated in
Virgin Islands, British
Fiscal year end
March 31
SEC CIK
1723980

Frequently asked questions

What exchange is China SXT Pharmaceuticals, Inc. listed on?

China SXT Pharmaceuticals, Inc. trades on the Nasdaq under the ticker symbol SXTC.

What industry is China SXT Pharmaceuticals, Inc. in?

China SXT Pharmaceuticals, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.

Where is China SXT Pharmaceuticals, Inc. headquartered?

China SXT Pharmaceuticals, Inc.'s business address on file with the SEC is in Taizhou.

When does China SXT Pharmaceuticals, Inc.'s fiscal year end?

China SXT Pharmaceuticals, Inc.'s fiscal year ends on March 31.

How much revenue did China SXT Pharmaceuticals, Inc. report?

China SXT Pharmaceuticals, Inc. reported $1.9M in revenue for calendar year 2023, according to its SEC filings.